Recently, Vertiflex, a minimally invasive spine surgery equipment company from California, announced that it has received endeavour Vision and H. I. G. BioHealth Partners led a $40 million financing. Participants in this round of financing include investment institutions such as New Enterprise Associates, Thomas, McNerney & Partners and Alta Partners.
Founded in 2005 and headquartered in Carlsbad, Calif., Vertiflex develops minimally invasive spinal surgery equipment. Its unique lumbar decompression technology provides a third way to treat spinal stenosis in addition to conservative treatment and traditional spinal surgery.
Lumbar spinal stenosis is a common disease in orthopedics. The causes of it are congenital lumbar spinal stenosis, degenerative diseases and spinal cord stenosis caused by trauma or lumbar surgery. The disease has approximately 500,000 new cases each year in the United States. Spinal stenosis can exert pressure on the spinal cord, causing pain, numbness, muscle weakness, or loss of bladder and intestinal function.
(Superion product display)
Vertiflex's main product, the Superion system, is a minimally invasive spinal implant that treats moderate stenosis. By placing the Superion system, the patient can reduce the pressure on the lumbar nerves and reduce the pain. The system completed a randomized controlled trial of 391 patients and received pre-market approval (PMA) from the FDA in May 2015.
From January this year, Superion system will receive the American Medical Association (American Medical Association) currently use the term medical services (Current Procedural Terminology, CPT) Code Description of Class I, the code normally used for health care workers and insurance companies, to support remote Medical reimbursement and other matters.
Improve Immunity Plant Extract
Improve Immunity Plant Extract,Ginseng Extract,Mulberry Powder,Seabuckthorn Powder
Fufeng Sinuote Biotechnology Co.,Ltd. , https://www.ffsinuoteplant.com